Vascular Solutions to Present at the 27th Annual Piper

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Vascular Solutions to Present at the 27th Annual Piper Jaffray Healthcare Conference

MINNEAPOLIS, Nov. 17, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq: VASC ) today announced that the Company is scheduled to participate at the 27 th Annual Piper Jaffray Healthcare Conference in New York City on Tuesday, December 1 at 12:00pm (EST). Howard Root, CEO, will join a live panel discussion: Insights from Medtech Founder CEOs. 

About Piper Jaffray

Piper Jaffray is a leading investment bank and asset management firm serving clients in the U.S. and internationally. A proven advisory team combines deep product and sector expertise with ready access to global capital. Founded in 1895, the firm is headquartered in Minneapolis and has offices across the United States and in London, Hong Kong and Zurich. For more information, connect to http://www.piperjaffray.com/ .

About Vascular Solutions

Vascular Solutions, Inc. is an innovative medical device company that focuses on developing unique clinical solutions for coronary and peripheral vascular procedures. The company’s product line consists of more than 90 products and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein specialists through its direct U.S. sales force and international independent distributor network.

For further information, connect to www.vasc.com .

Contact: Philip Nalbone, VP Vascular Solutions, Inc. (763) 656-4300

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 37

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 34

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

FuboTV Prepares for Q3 2024 Financial Results Release

Updated Category News Views 101

FuboTV to Reveal Q3 2024 Financial Insights FuboTV Inc. (d/b/a Fubo) (NYSE: FUBO), a prominent player in the sports streaming arena, has announced a significant event on the horizon. They will release their third quarter financial results for 2024 early in the market day, a move that provides a valuable update for investors and followers alike. Details about the Financial...

Continue Reading
Coinbase's Gokul Rajaram's Share Sale Highlights Market Trends

Updated Category News Views 262

Gokul Rajaram of Coinbase Sells Shares Recently, Gokul Rajaram, a director at Coinbase Global, Inc. (NASDAQ:COIN), made headlines by selling shares worth $64,536. This transaction took place in September, when he sold 400 shares at a price of $161.34 each. Such moves often attract a lot of attention from those tracking the cryptocurrency market and its developments...

Continue Reading
Robinhood's New Fund Unlocks Private AI Investments for All

Updated Category News Views 200

Robinhood Ventures' Bold Move Into Private AI Investments Robinhood Markets Inc. (NASDAQ: HOOD) is set to revolutionize the investment landscape by giving retail investors access to private startups focused on artificial intelligence (AI). Despite widespread chatter about a potential bubble in the AI sector, the company is moving forward with this innovative approach....

Continue Reading
IRG, PREP, and DWREP Join Forces for Major Site Redevelopment

Updated Category News Views 184

Investment in Future Growth In an exciting development, Industrial Realty Group, LLC (IRG), along with Provider Real Estate Partners (PREP) and DW Real Estate Partners, LLC (DWREP), have embarked on a significant project to redevelop an industrial property in Ohio. The trio has successfully acquired the Hilliard Commerce Center, a sprawling 177,680 square-foot facility...

Continue Reading
Understanding Publicis Groupe’s Recent Share Trading Activity

Updated Category News Views 149

Overview of Share Trading Activities Publicis Groupe recently engaged in notable share trading activities, reflecting its strategic moves in the market. This trading involves shares acquired as part of a pre-approved program by the company's shareholders, aimed at enhancing its capital management. Transaction Details During the latest trading window, Publicis Groupe...

Continue Reading